Earnings Whispers: The Market's True Earnings Expectation

This Week's Confirmed Earnings

Loading…

The Earnings Quarter

Every Stock Runs the Same Three-Month Loop

A company reports once every three months. Its stock spends the other eighty-nine days deciding what the report meant — and that path has a shape. Knowing whether a stock is still drifting on its last report, sitting in the quiet middle, or already running up into the next one tells you which questions matter now, and where the odds are quietly tilting.

53% Gap higher after reporting

+3.5% Average up gap previous close to open

−3.8% Average down gap previous close to open

The gap is the opening move. What happens over the following three months is a different question — and a more useful one.

A worked example, not an average: JPM across its own earnings quarters, indexed to its price two weeks before each report.

Read the research

The Whisper Report^®

See all

Earnings vs Jobs

Monday, August 10, 2026

The jobs numbers disappointed once again, but the market doesn’t seem to be buying it.

AMAT

CSCO

LQDA

RSKD

HRB

HQY

Read Report

Top Earnings News

See all

The recent, most closely watched, earnings results.

Outlook Therapeutics Reported In-line with Estimates

Friday, August 14, 2026 at 7:15 AM

Outlook Therapeutics (OTLK) reported a loss of $0.09 per share on revenue of $0.01 million for the fiscal third quarter ended June 2026. The consensus estimate was a loss of $0.09 per share on revenue of $1.20 million. The company reported in-line with consensus estimates while revenue fell 99.40% compared to the same quarter a year ago.

Outlook Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focuses on developing ONS-5010 which is a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration which is in clinical stage. Outlook Therapeutics Inc., formerly known as Oncobiologics Inc., is based in Cranbury, United States.

Nu Holdings Beat Expectations

Thursday, August 13, 2026 at 5:40 PM

Nu Holdings (NU) reported earnings of $0.22 per share on revenue of $5.51 billion for the second quarter ended June 2026. The consensus earnings estimate was $0.20 per share on revenue of $5.45 billion. The Earnings Whisper number was $0.21 per share. The company beat expectations by 4.76% while revenue grew 50.29% on a year-over-year basis.

Nu is one of the world’s largest digital banking platforms, serving more than 48 million customers across Brazil, Mexico and Colombia.

AirJoule Technologies Beat Consensus Estimates

Thursday, August 13, 2026 at 5:26 PM

AirJoule Technologies (AIRJ) reported a loss of $0.05 per share on revenue of $0.00 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.08 per share on revenue of $0.50 million. The company beat consensus estimates by 37.50%.

AirJoule Technologies Corporation is a leading platform technology that unleashes the power of water from air.